Replies to post #385942 on Elite Pharmaceuticals Inc (ELTP)

[rrr2003]

At 2.53 billion in annual US sales, I'd say there is plenty of room for the generic players to compete, including ELTP, when the time comes.

No generic availability since it’s not off patent yet, but others have already filed. We’re not first in line. Would be a year out at least when including prep to file + FDA review + launch.